Erlotinib versus carboplatin/vinorelbine in elderly patients (age 70 or older) with advanced non-small cell lung carcinoma (NSCLC): A randomized phase II study of the German Thoracic Oncology Working Group.
暂无分享,去创建一个
P. Schnabel | C. Kortsik | M. Reck | Mark G Thomas | M. Eiff | K. Deppermann | J. Pawel | J. Fischer | S. Bohnet | W. Koester | Mark G. Thomas